AT366681B - Verfahren zur herstellung von neuen mono-, diund trisubstituierten flavanderivaten - Google Patents

Verfahren zur herstellung von neuen mono-, diund trisubstituierten flavanderivaten

Info

Publication number
AT366681B
AT366681B AT0191879A AT191879A AT366681B AT 366681 B AT366681 B AT 366681B AT 0191879 A AT0191879 A AT 0191879A AT 191879 A AT191879 A AT 191879A AT 366681 B AT366681 B AT 366681B
Authority
AT
Austria
Prior art keywords
producing new
tri substituted
new mono
flavan derivatives
substituted flavan
Prior art date
Application number
AT0191879A
Other languages
German (de)
English (en)
Other versions
ATA191879A (de
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Priority to AT579580A priority Critical patent/AT367415B/de
Priority to AT579680A priority patent/AT367416B/de
Publication of ATA191879A publication Critical patent/ATA191879A/de
Application granted granted Critical
Publication of AT366681B publication Critical patent/AT366681B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/60Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/82Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups
    • C07C49/835Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups having unsaturation outside an aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/84Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Oncology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pyrane Compounds (AREA)
AT0191879A 1978-03-15 1979-03-14 Verfahren zur herstellung von neuen mono-, diund trisubstituierten flavanderivaten AT366681B (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AT579580A AT367415B (de) 1978-03-15 1980-11-27 Verfahren zur herstellung von neuen mono-, diund trisubstituierten flavanderivaten
AT579680A AT367416B (de) 1978-03-15 1980-11-27 Verfahren zur herstellung von neuen mono-, diund trisubstituierten flavanderivaten

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1025178 1978-03-15

Publications (2)

Publication Number Publication Date
ATA191879A ATA191879A (de) 1981-09-15
AT366681B true AT366681B (de) 1982-04-26

Family

ID=9964425

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0191879A AT366681B (de) 1978-03-15 1979-03-14 Verfahren zur herstellung von neuen mono-, diund trisubstituierten flavanderivaten

Country Status (32)

Country Link
US (1) US4461907A (fr)
EP (2) EP0004579B1 (fr)
JP (1) JPS54130575A (fr)
AR (2) AR223478A1 (fr)
AT (1) AT366681B (fr)
AU (1) AU529313B2 (fr)
CA (1) CA1193273A (fr)
CS (1) CS231964B2 (fr)
DD (1) DD142340A5 (fr)
DK (1) DK105379A (fr)
EG (1) EG14189A (fr)
ES (3) ES478605A1 (fr)
FI (1) FI790863A (fr)
GR (1) GR67250B (fr)
HU (2) HU187755B (fr)
IL (1) IL56871A (fr)
IN (2) IN150229B (fr)
IT (1) IT1116848B (fr)
MC (1) MC1254A1 (fr)
MY (1) MY8500223A (fr)
NO (3) NO154167C (fr)
NZ (1) NZ189906A (fr)
OA (1) OA06289A (fr)
PH (1) PH18415A (fr)
PL (3) PL122049B1 (fr)
PT (1) PT69349A (fr)
RO (4) RO82173B (fr)
SU (3) SU1072805A3 (fr)
YU (3) YU61679A (fr)
ZA (1) ZA791198B (fr)
ZM (1) ZM2479A1 (fr)
ZW (1) ZW5979A1 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ193316A (en) * 1979-04-10 1984-07-31 Hoffmann La Roche 3-alkoxyflavone derivatives and pharmaceutical compositions
US4588733A (en) * 1984-10-19 1986-05-13 Merrell Dow Pharmaceuticals Inc. 2-phenylpyrano[2,3-b]pyridines and their use in inhibiting viruses
US4758679A (en) * 1986-07-18 1988-07-19 Pennwalt Corporation Preparation of 7-(3-(propylamino)-2-hydroxypropoxy)flavone
LU86715A1 (fr) * 1986-12-16 1988-07-14 Oreal Composition cosmetique contenant des derives hydroxyles de chalcone et son utilisation pour la protection de la peau et des cheveux contre les radiations lumineuses,nouveaux derives hydroxyles de chalcone utilises et leur procede de preparation
KR0139296B1 (ko) * 1988-11-21 1998-05-15 가와무라 시게꾸니 칼콘 유도체 및 그 제조 방법
US5063244A (en) * 1990-07-30 1991-11-05 Development Center For Biotechnology Process for the isolation of antifungal agents (5-methoxy-7-hydroxyflavan) from dragon's blood resin and its use in agriculture
US5276058A (en) * 1993-06-09 1994-01-04 Nippon Hypox Laboratories Incorporated 3,4-dihydroxychalcone derivatives
IL118657A0 (en) * 1996-06-14 1996-10-16 Arad Dorit Inhibitors for picornavirus proteases
IL122591A0 (en) 1997-12-14 1998-06-15 Arad Dorit Pharmaceutical compositions comprising cystein protease inhibitors
US6555523B1 (en) 1999-07-08 2003-04-29 Patrick T. Prendergast Use of cirsiliol and derivatives to treat infections
US6677350B1 (en) 1999-09-22 2004-01-13 Advanced Life Sciences, Inc. Beta-fluoroethyl thiourea compounds and use
JP4742215B2 (ja) * 2003-06-23 2011-08-10 Jnc株式会社 クロマン化合物、この化合物を含有する液晶組成物およびこの液晶組成物を含有する液晶表示素子
ATE342950T1 (de) * 2003-06-23 2006-11-15 Chisso Petrochemical Corp Chromanverbindung, flüssigkristallzusammensetzung enthaltend die verbindung und flüssigkristallanzeigeelement enthaltend die flüssigkristallzusammensetzung
CN109134205B (zh) 2004-05-28 2022-07-19 尤尼根公司 作为双核酶强效抑制剂的二芳基烷烃
KR101233223B1 (ko) * 2004-12-21 2013-02-14 제이엔씨 석유 화학 주식회사 크로만환을 가지는 액정 화합물, 액정 조성물 및 이 액정조성물을 함유하는 액정 표시소자
JP5126942B2 (ja) * 2006-12-26 2013-01-23 静岡県公立大学法人 5,7−ジデオキシエピガロカテキンガレート、その製法及び抗インフルエンザウイルス剤
WO2014162320A2 (fr) * 2013-04-04 2014-10-09 Sphaera Pharma Pvt. Ltd. Nouveaux analogues d'épicatéchine et polyphénols associés

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1518006A1 (de) * 1951-01-28 1969-01-16 Merck Ag E Verfahren zur Herstellung von wasserloeslichen Flavanoidderivaten
FR1221869A (fr) * 1959-01-15 1960-06-07 Coupin Lab Procédé de préparation de dérivés solubles dans l'eau à partir des glucosides flavanoniques
ES265050A1 (es) * 1960-02-23 1961-06-16 Orsymonde Ltd Procedimiento de preparación de derivados insaturados de la trihidroxiacetofenona
CH473114A (de) * 1963-08-28 1969-05-31 Merck Ag E Verfahren zur Herstellung von substituierten Flavanoiden
DE1493976C3 (de) * 1964-01-18 1973-09-13 Merck Patent Gmbh, 6100 Darmstadt Substituierte Flavandenvate sowie Verfahren zu ihrer Herstellung
US3499763A (en) * 1967-05-01 1970-03-10 Ibm Bis phenols as high opacity diazotype couplers
FR1583930A (fr) * 1968-06-27 1969-12-05
GB1283981A (en) * 1969-03-05 1972-08-02 Orsymonde 2,4,6-trihydroxy chalcone derivatives
US3678044A (en) * 1970-10-22 1972-07-18 Chevron Res Substituted flavanones
NZ192641A (en) * 1979-01-26 1984-10-19 Hoffmann La Roche Substituted acetophenones and pharmaceutical compositions

Also Published As

Publication number Publication date
YU271582A (en) 1983-02-28
RO82526B (ro) 1984-11-30
AR225175A1 (es) 1982-02-26
AU529313B2 (en) 1983-06-02
CA1193273A (fr) 1985-09-10
AU4510879A (en) 1979-09-20
ZM2479A1 (en) 1981-01-21
IN151598B (fr) 1983-06-04
PL122049B1 (en) 1982-06-30
PT69349A (en) 1979-04-01
HU187755B (en) 1986-02-28
JPS54130575A (en) 1979-10-09
RO86258A (fr) 1985-03-15
YU61679A (en) 1983-02-28
HUT35173A (en) 1985-06-28
EP0051061A3 (fr) 1982-06-09
EP0004579B1 (fr) 1982-08-18
ZW5979A1 (en) 1980-10-15
IL56871A (en) 1986-02-28
MC1254A1 (fr) 1980-01-14
EG14189A (en) 1984-09-30
PH18415A (en) 1985-06-24
IL56871A0 (en) 1979-05-31
ZA791198B (en) 1980-11-26
US4461907A (en) 1984-07-24
NZ189906A (en) 1985-07-31
NO154167C (no) 1986-07-30
ES482787A1 (es) 1980-08-01
YU271482A (en) 1983-02-28
NO840627L (no) 1979-09-18
EP0004579A1 (fr) 1979-10-17
GR67250B (fr) 1981-06-25
EP0051061A2 (fr) 1982-05-05
DD142340A5 (de) 1980-06-18
SU986296A3 (ru) 1982-12-30
CS231964B2 (en) 1985-01-16
DK105379A (da) 1979-09-16
AR223478A1 (es) 1981-08-31
ATA191879A (de) 1981-09-15
RO78419A (fr) 1982-03-24
PL214115A1 (fr) 1980-06-16
NO154167B (no) 1986-04-21
IN150229B (fr) 1982-08-21
RO82173B (ro) 1984-04-30
RO82173A (fr) 1984-04-02
FI790863A (fi) 1979-09-16
ES478605A1 (es) 1980-01-16
OA06289A (fr) 1981-06-30
ES482788A1 (es) 1980-09-01
PL121969B1 (en) 1982-06-30
MY8500223A (en) 1985-12-31
NO840626L (no) 1979-09-18
RO86258B (ro) 1985-03-31
NO790871L (no) 1979-09-18
SU1072805A3 (ru) 1984-02-07
IT7948347A0 (it) 1979-03-14
IT1116848B (it) 1986-02-10
SU991948A3 (ru) 1983-01-23
RO82526A (fr) 1984-10-31

Similar Documents

Publication Publication Date Title
AT378768B (de) Verfahren zur herstellung von neuen 1-sulfo-2-oxoazetidin-derivaten
AT376212B (de) Verfahren zur herstellung von neuen 1,2,4-triazolderivaten
AT366681B (de) Verfahren zur herstellung von neuen mono-, diund trisubstituierten flavanderivaten
AT369375B (de) Verfahren zur herstellung von neuen 3-vinylcephalosporin-derivaten
AT378957B (de) Verfahren zur herstellung von neuen triazolderivaten
AT376654B (de) Verfahren zur herstellung von neuen 1-phenyl-2cyclohexen-1-alkylamin-derivaten
AT373871B (de) Verfahren zur herstellung von neuen alpha -phenylpyrrolidin-2-methanol-derivaten
AT364097B (de) Verfahren zur herstellung von neuen bicyclooctanderivaten
AT379388B (de) Verfahren zur herstellung von neuen 4-chinolonderivaten
AT361922B (de) Verfahren zur herstellung von neuen chromanon- derivaten
AT366392B (de) Verfahren zur herstellung von neuen, diuretisch wirksamen steroid-spiro- oxazolidinon-derivaten
AT371478B (de) Verfahren zur herstellung von neuen 7-alphamethoxycephalosporinderivaten
AT373259B (de) Verfahren zur herstellung von neuen 1oxadethiacephalosporin-derivaten
AT375076B (de) Verfahren zur herstellung von neuen ergolinderivaten
AT374451B (de) Verfahren zur herstellung von neuen benzylidenderivaten
AT373891B (de) Verfahren zur herstellung von neuen rifamycinderivaten
AT373896B (de) Verfahren zur herstellung von neuen ergopeptidalkaloidderivaten
ATA579580A (de) Verfahren zur herstellung von neuen mono-, diund trisubstituierten flavanderivaten
ATA579680A (de) Verfahren zur herstellung von neuen mono-, diund trisubstituierten flavanderivaten
AT381940B (de) Verfahren zur herstellung von neuen ergolinderivaten
AT364458B (de) Verfahren zur herstellung von neuen oleandomycinderivaten
AT370725B (de) Verfahren zur herstellung von neuen 16-methoxy-16-methyl-prostaglandin-e1-derivaten
AT372077B (de) Verfahren zur herstellung von neuen benzylidenderivaten
ATA435479A (de) Verfahren zur herstellung von neuen 20-methyl-13, 14-didehydro-pgi2-derivaten
AT373890B (de) Verfahren zur herstellung von neuen 1,4;3,6-dianhydro-2,5-diazido-2,5-didesoxy-hexit-derivaten

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee